Company Update (NYSE:COV): Covidien Announces Start of Enrollment in Two Neurovascular Clinical Trials

[Business Wire] – Covidien plc announced today the start of enrollment in two clinical trials designed to further underscore the safety and effectiveness of the company’s advanced neurovascular solu Read more on this. . . . → Read More: Company Update (NYSE:COV): Covidien Announces Start of Enrollment in Two Neurovascular Clinical Trials Similar Articles: Company Update (NYSE:COV): Covidien Acquires Reverse Medical Corporation Company Update: Covidien plc (NYSE:COV) – FDA Approves Changes to Manufacturing Process for Covidien’s Pipeline™ Embolization Device Company Update: Covidien plc (NYSE:COV) – Covidien Opens Advanced Medical Technology Center in Brazil
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.